Perspective Therapeutics, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Perspective Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2011 to 2023.
  • Perspective Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $166M.
  • Perspective Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $785K, a 2704% increase from 2022.
  • Perspective Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $28K, a 100% decline from 2021.
  • Perspective Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $64.7M, a 6407% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $785K +$757K +2704% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $28K -$64.7M -100% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $64.7M +$63.7M +6407% Jul 1, 2020 Jun 30, 2021 10-KT 2023-05-01
2020 $994K -$6.38M -86.5% Jul 1, 2019 Jun 30, 2020 10-KT 2023-05-01
2019 $7.37M +$6.85M +1315% Jul 1, 2018 Jun 30, 2019 10-K 2021-09-27
2018 $521K +$530K Jul 1, 2017 Jun 30, 2018 10-K 2020-09-25
2017 -$9K -$48K -123% Jul 1, 2016 Jun 30, 2017 10-K 2019-09-27
2016 $39K Jul 1, 2015 Jun 30, 2016 10-K 2018-09-26
2013 $3.3M +$193K +6.2% Jul 1, 2012 Jun 30, 2013 10-K 2013-09-30
2012 $3.1M +$93.6K +3.11% Jul 1, 2011 Jun 30, 2012 10-K 2013-09-30
2011 $3.01M Jul 1, 2010 Jun 30, 2011 10-K/A 2012-10-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.